ATI RN
ATI Pharmacology Assessment 1 Questions
Extract:
Question 1 of 5
A nurse is assessing a client who is taking beclomethasone. Which of the following findings is the priority to report to the provider?
Correct Answer: A
Rationale: A white coating in the mouth can indicate oral thrush, a common side effect of inhaled corticosteroids like beclomethasone, requiring prompt treatment.
Question 2 of 5
A nurse is talking with a client who has a new prescription for an ipratropium inhaler to treat exercise-induced bronchospasm. Which of the following client statements should the nurse report to the provider?
Correct Answer: C
Rationale: An allergy to atropine is significant because ipratropium is chemically related to atropine, which could lead to a severe allergic reaction.
Question 3 of 5
A nurse is caring for a client who has hyperlipidemia and a new prescription for colesevelam. The nurse should monitor the client for which of the following manifestations as an adverse effect of colesevelam?
Correct Answer: D
Rationale: Constipation is a common adverse effect of colesevelam. This medication binds to bile acids in the intestines, which can lead to gastrointestinal side effects such as constipation.
Question 4 of 5
A nurse is caring for a client following a bronchoscopy with moderate sedation. Which of the following actions should the nurse take? (Select all that apply.)
Correct Answer: A,B,C,D,F
Rationale: Assessing the gag reflex prevents aspiration. Listening to breath sounds detects abnormalities. Monitoring oxygen saturation ensures adequate oxygenation. Monitoring for bleeding is necessary due to airway trauma. Observing for pneumothorax is important as it can occur post-bronchoscopy.
Question 5 of 5
A nurse is reviewing the laboratory findings for a female client who is taking zidovudine to treat HIV. Which of the following should the nurse identify as an adverse finding associated with this medication?
Correct Answer: A
Rationale: A neutrophil count of 650/mm³ indicates neutropenia, a known adverse effect of zidovudine, increasing the risk of infections.